Literature DB >> 23263578

Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome.

Mathieu Jozwiak1, Serena Silva, Romain Persichini, Nadia Anguel, David Osman, Christian Richard, Jean-Louis Teboul, Xavier Monnet.   

Abstract

OBJECTIVE: Acute respiratory distress syndrome might be associated with an increase in extravascular lung water index and pulmonary vascular permeability index, which can be measured by transpulmonary thermodilution. We tested whether extravascular lung water index and pulmonary vascular permeability index are independent prognostic factors in patients with acute respiratory distress syndrome.
DESIGN: Retrospective study.
SETTING: Medical intensive care unit. PATIENTS: Two hundred consecutive acute respiratory distress syndrome patients (age = 57 ± 17, Simplified Acute Physiology Score II = 57 ± 20, overall day-28 mortality = 54%). MEASUREMENTS: Extravascular lung water index and pulmonary vascular permeability index were collected (PiCCO device, Pulsion Medical Systems) at each day of the acute respiratory distress syndrome episode. MAIN
RESULTS: The maximum values of extravascular lung water index and pulmonary vascular permeability index recorded during the acute respiratory distress syndrome episode (maximum value of extravascular lung water index and maximum value of pulmonary vascular permeability index, respectively) were significantly higher in nonsurvivors than in survivors at day-28 (mean ± SD: 24 ± 10 mL/kg vs. 19 ± 7 mL/kg of predicted body weight, p < 0.001 [t-test] for maximum value of extravascular lung water index and median [interquartile range]: 4.4 [3.3-6.1] vs. 3.5 [2.8-4.4], p = 0.001 for maximum value of pulmonary vascular permeability index, Wilcoxon's test). In multivariate analyses, maximum value of extravascular lung water index or maximum value of pulmonary vascular permeability index, Simplified Acute Physiology Score II, maximum blood lactate, mean positive end-expiratory pressure, mean cumulative fluid balance, and the minimal ratio of arterial oxygen pressure over the inspired oxygen fraction were all independently associated with day-28 mortality. A maximum value of extravascular lung water index >21 mL/kg predicted day-28 mortality with a sensitivity of (mean [95% confidence interval]) 54% (44-63)% and a specificity of 73% (63-82)%. The mortality rate was 70% in patients with a maximum value of extravascular lung water index >21 mL/kg and 43% in the remaining patients (p = 0.0003). A maximum value of pulmonary vascular permeability index >3.8 predicted day-28 mortality with a sensitivity of (mean [95% confidence interval]) 67% (57-76)% and a specificity of 65% (54-75)%. The mortality rate was 69% in patients with a maximum value of pulmonary vascular permeability index >3.8 and 37% in the group with a maximum value of pulmonary vascular permeability index ≤ 3.8 (p < 0.0001).
CONCLUSIONS: Extravascular lung water index and pulmonary vascular permeability index measured by transpulmonary thermodilution are independent risk factors of day-28 mortality in patients with acute respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23263578     DOI: 10.1097/CCM.0b013e31826ab377

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  72 in total

Review 1.  Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysis.

Authors:  Xavier Monnet; Paul Marik; Jean-Louis Teboul
Journal:  Intensive Care Med       Date:  2016-01-29       Impact factor: 17.440

Review 2.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

3.  Guiding fluid resuscitation in critically ill patients: how to evaluate the available tools?

Authors:  Kees H Polderman; Berthold Bein; Stefan Kluge; Bernd Saugel
Journal:  Intensive Care Med       Date:  2015-03-27       Impact factor: 17.440

4.  Can one size fit all? The fine line between fluid overload and hypovolemia.

Authors:  Thierry Boulain; Maurizio Cecconi
Journal:  Intensive Care Med       Date:  2015-02-06       Impact factor: 17.440

5.  Goal-Directed Fluid Therapy: What the Mind Does Not Know, the Eye Cannot See.

Authors:  Joshua A Bloomstone; Randal O Dull; Lais H C Navarro
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

Review 6.  Physiology-guided management of hemodynamics in acute respiratory distress syndrome.

Authors:  Gustavo A Cortes-Puentes; Richard A Oeckler; John J Marini
Journal:  Ann Transl Med       Date:  2018-09

7.  Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.

Authors:  Akira Kuriyama; Seigo Urushidani
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

8.  Positive Cumulative Fluid Balance Is Associated With Mortality in Pediatric Acute Respiratory Distress Syndrome in the Setting of Acute Kidney Injury.

Authors:  Matt S Zinter; Aaron C Spicer; Kathleen D Liu; Benjamin E Orwoll; Mustafa F Alkhouli; Paul R Brakeman; Carolyn S Calfee; Michael A Matthay; Anil Sapru
Journal:  Pediatr Crit Care Med       Date:  2019-04       Impact factor: 3.624

Review 9.  Tidal volume and plateau pressure use for acute lung injury from 2000 to present: a systematic literature review.

Authors:  Dharmvir S Jaswal; Janice M Leung; Junfeng Sun; Xizhong Cui; Yan Li; Steven Kern; Judith Welsh; Charles Natanson; Peter Q Eichacker
Journal:  Crit Care Med       Date:  2014-10       Impact factor: 7.598

10.  Accuracy of ultrasound B-lines score and E/Ea ratio to estimate extravascular lung water and its variations in patients with acute respiratory distress syndrome.

Authors:  Benoît Bataille; Guillaume Rao; Pierre Cocquet; Michel Mora; Bruno Masson; Jean Ginot; Stein Silva; Pierre-Etienne Moussot
Journal:  J Clin Monit Comput       Date:  2014-05-13       Impact factor: 2.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.